Your AI-Powered Market Intelligence

Wednesday, October 21, 2026
RSS


← All Stories

Earnings

Okta's Earnings Beat: A Sign of Growing Demand for Identity Security Solutions

Okta's Q2 FY2027 earnings reveal a 15% stock surge and highlight the rising importance of identity security solutions.

Aug 27, 2026
Earnings

Walmart's Earnings Disappointment: A Warning for Consumer Stocks

Walmart's disappointing earnings raise concerns for the consumer sector amidst inflation pressures.

Aug 20, 2026
Earnings

Cisco's Earnings Disappointment: A Cautionary Tale for AI-Driven Stocks

Cisco's disappointing earnings have triggered a 6% sell-off, raising alarms for AI-driven stocks and their valuations.

Aug 13, 2026
Earnings

Air Canada's Annual Forecast Reinstated Amid Fuel Price Concerns

Air Canada reinstates its annual forecast, highlighting operational confidence amid rising oil prices and fuel price volatility risks.

Aug 12, 2026
Earnings

Phillips 66 Reports Strong Earnings Amid Geopolitical Tensions

Phillips 66 beats quarterly estimates, driven by strong refining margins amid geopolitical uncertainties.

Aug 6, 2026
Earnings

Phillips 66 Reports Earnings Beat Amid Geopolitical Tensions: Implications for US Refiners

Phillips 66 exceeds earnings estimates thanks to enhanced refining margins amid geopolitical tensions, impacting the US energy sector.

Aug 5, 2026
Earnings

SpaceX Earnings Report: What Investors Should Expect

Investors are eyeing SpaceX's first earnings report post-IPO with high volatility expectations.

Aug 4, 2026
Earnings

Pfizer's Q2 Earnings Beat Signals Strong Non-Covid Growth

Pfizer's Q2 2026 earnings surpassed expectations, reflecting robust performance and strong non-Covid product growth.

Aug 4, 2026
Earnings

Palantir's Commercial AI Surge: A Game Changer for Investors

Palantir's stock surged 16% post-Q2 earnings, fueled by a rising demand for commercial AI solutions.

Aug 4, 2026
Earnings

Supernus and Indivior Merger: Creating a CNS Pharmaceuticals Powerhouse

Supernus Pharmaceuticals and Indivior Pharmaceuticals announce a strategic all-stock merger to enhance their CNS biopharmaceutical leadershi…

Aug 3, 2026
Earnings

Microsoft's Q4 Earnings: Strategies for Latecomers to Capitalize on the Surge

Microsoft's Q4 earnings have led to record share appreciation, prompting expert options strategies for traders.

Jul 31, 2026
Earnings

Vertiv's 17% Stock Plunge: A Temporary Setback or a Warning Sign?

Vertiv's stock fell 17% after a revenue miss. CEO assures demand for AI infrastructure remains strong.

Jul 30, 2026